Harmony Biosciences Holdings, Inc. · NASDAQ:HRMY
Budur Kumar sold 38,452 Harmony Biosciences Holdings, Inc. shares (Form 4)
Traded Sep 16 to Sep 18, 2026 · Filed Sep 18, 2026
From Sep 16 to Sep 18, 2026, Budur Kumar (CHIEF MEDICAL OFFICER) sold 38,452 Harmony Biosciences Holdings, Inc. shares at an average US$43.05 for US$1.66M, leaving 13,115 shares. Filed Sep 18, 2026 (Form 4).
- Sold
- 38,452 shares
- Price
- US$43.05 average (US$43.00 to US$43.05)
- Value
- US$1.66M
- Holding after
- 13,115 shares
- Trading plan
- No
- Role
- CHIEF MEDICAL OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 16, 2026 | Common Stock | Option exercise | 900 | US$30.69 | 14,015 | Direct |
| Sep 16, 2026 | Common Stock | Option exercise | 900 | US$30.27 | 14,915 | Direct |
| Sep 16, 2026 | Common Stock | Sale | 1,800 | US$43.01 | 13,115 | Direct |
| Sep 17, 2026 | Common Stock | Option exercise | 400 | US$30.69 | 13,515 | Direct |
| Sep 17, 2026 | Common Stock | Option exercise | 400 | US$30.27 | 13,915 | Direct |
| Sep 17, 2026 | Common Stock | Sale | 800 | US$43.00 | 13,115 | Direct |
| Sep 18, 2026 | Common Stock | Option exercise | 10,406 | US$30.69 | 23,521 | Direct |
| Sep 18, 2026 | Common Stock | Option exercise | 25,446 | US$30.27 | 48,967 | Direct |
| Sep 18, 2026 | Common Stock | Sale | 35,852 | US$43.05 | 13,115 | Direct |
Source
Related
- Harmony Biosciences Holdings, Inc.
- Budur Kumar
- Harmony Biosciences Holdings, Inc. shareholders
- Form 4 · Budur Kumar · Sep 9, 2026
- Form 4 · Budur Kumar · May 18, 2026
- Schedule 13G · Vanguard Portfolio Management LLC · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Zaeske Adam H. · Apr 9, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Schedule 13G/A · FMR LLC · Feb 5, 2026